News
AHA scientific statement highlights cardiorenal benefit of new diabetes drugs
October 1, 2020
SGLT2 inhibitors and GLP-1 receptor agonists should be considered in people with type 2 diabetes and chronic kidney disease to protect against heart disease and kidney disease progression.
![1]()
News
DAPA-CKD resets eGFR floor for safe SGLT2 inhibitor use
September 25, 2020
Until now, SGLT2 inhibitors were for patients with an eGFR of at least 30 mL/min per m2. New evidence moves the threshold down to 25.
News
‘Cautious’ DOAC underdosing in AFib may push mortality higher
September 21, 2020
Risk-averse clinicians might be doing more harm than good by prescribing direct oral anticoagulants at lower-than-recommended dosages in hope of avoiding bleeding complications, suggests a study.
![1]()
News
Observational study again suggests lasting impact of COVID-19 on heart
September 21, 2020
Cardiac MR study raises concern for myocarditis post COVID in some young athletes, but commentators suggest these and other such findings are too weak to suggest routine screening with CMR.
![1]()
News
Many providers don’t follow hypertension guidelines
September 17, 2020
Most health care professionals rely on clinic BP measurements to make a new diagnosis of hypertension, and view pressure measured manually with a cuff and stethoscope as accurate.
News
The earlier the better for colchicine post-MI: COLCOT
September 14, 2020
One substudy supported in-hospital initiation of colchicine and a second offered clues as to who may respond or experience tell-tale GI events.
![1]()
News
MIS-C cardiac evaluation requires more than EF
September 9, 2020
Children with COVID-19 and multisystem inflammatory syndrome need a thorough coronary work-up to evaluate later-phase cardiac injury and dysfunction.
![1]()
News
Statins linked to reduced mortality in COVID-19
September 3, 2020
A pooled analysis of available data suggest moderate- to high-intensity statin therapy may be beneficial in patients with COVID-19, researchers said.
![1]()
News
Minidose edoxaban may safely cut AFib stroke risk in the frail, very elderly
September 3, 2020
Those who took the factor Xa inhibitor edoxaban (Savaysa) at the off-label dosage of 15 mg once daily showed a two-thirds drop in risk for stroke or systemic embolism, compared with patients who received placebo.
![1]()
News
REALITY trial supports restrictive transfusion in anemic MI
September 2, 2020
Restrictive transfusion proves more effective and less costly than liberal transfusion.
